Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026)
Lensar (LNSR) posted quarterly Net Income towards Common Stockholders of $18.9 million for Q1 2026, up 169.17% year-over-year from $7.0 million in Q1 2025, and up 1397.26% quarter-over-quarter from -$1.5 million in Q4 2025.
Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Net Income towards Common Stockholders for 8 consecutive years, with $18.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 169.17% year-over-year to $18.9 million; the TTM figure through Mar 2026 stood at $12.0 million (up 121.17% YoY), while the FY2025 annual figure was -$34.3 million, down 9.16% from the prior year.
- Net Income towards Common Stockholders improved to $18.9 million in Q1 2026 per LNSR's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $18.9 million in Q1 2026 and bottomed at -$27.3 million in Q1 2025.
- Historically, Net Income towards Common Stockholders has averaged -$4.8 million across 5 years, with a median of -$3.9 million in 2023.
- Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders slumped 1167.73% — and 2026, when it surged 169.17%.
- Lensar's Net Income towards Common Stockholders stood at -$2.5 million in 2022, then slumped by 57.67% to -$3.9 million in 2023, then slumped by 376.36% to -$18.7 million in 2024, then surged by 92.2% to -$1.5 million in 2025, then jumped by 1397.26% to $18.9 million in 2026.
- Business Quant data shows LNSR's Net Income towards Common Stockholders at $18.9 million in Q1 2026, -$1.5 million in Q4 2025, and -$3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Lensar | 105.26 Mn | 91.70 Mn | 9.78 Mn | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114,000.00 |
| Mar 31, 2026 | 18.91 Mn |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | -3.71 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -27.35 Mn |
| Dec 31, 2024 | -18.70 Mn |
| Sep 30, 2024 | -1.50 Mn |
| Jun 30, 2024 | -9.04 Mn |
| Mar 31, 2024 | -2.16 Mn |
| Dec 31, 2023 | -3.93 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | -8.75 Mn |
| Mar 31, 2023 | -4.27 Mn |
| Dec 31, 2022 | -2.49 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | -6.76 Mn |
| Mar 31, 2022 | -6.67 Mn |
| Dec 31, 2021 | -3.90 Mn |
| Sep 30, 2021 | -6.16 Mn |